|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/17 | (2015.01) |
| C12N 15/113 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| C12N2310/20 | (2017.05) | ||
| C07K 14/70503 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 14/70521 | (2013.01) | ||
| A61P 31/12 | (2006.01) | ||
| C07K 14/715 | (2006.01) | ||
| C07K 14/4703 | (2013.01) | ||
| C07K 14/705 | (2006.01) | ||
| A61K 35/17 | (2013.01) | ||
| C07K 14/47 | (2006.01) | ||
| A61P 31/00 | (2018.01) | ||
| C12N 9/22 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| C12N 15/113 | (2010.01) | ||
| C07K 14/7158 | (2013.01) | ||
| A61P 31/00 | (2006.01) | ||
| C12N 9/22 | (2013.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 31/12 | (2018.01) |
| (11) | Number of the document | 3529359 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17861792.4 |
| Date of filing the European patent application | 2017-10-18 | |
| (97) | Date of publication of the European application | 2019-08-28 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/057228 |
| Date | 2017-10-18 |
| (87) | Number | WO 2018/075664 |
| Date | 2018-04-26 |
| (30) | Number | Date | Country code |
| 201662409651 P | 2016-10-18 | US | |
| 201762452244 P | 2017-01-30 | US |
| (72) |
MORIARITY, Branden , US
WEBBER, Beau , US
CHOUDHRY, Modassir , US
ROSENBERG, Steven A. , US
PALMER, Douglas C. , US
RESTIFO, Nicholas P. , US
|
| (73) |
Regents of the University of Minnesota ,
600 McNamara Alumni Center
200 Oak Street S.E., Minneapolis, MN 55455-2020,
US
Intima Bioscience, Inc. , 3 Columbus Circle, New York, New York 10019, US The United States of America, as represented by the Secretary, Department of Health and Human Services , Office of Technology Transfer, National Institutes of Health, 6011 Executive Boulevard, Suite 325, MSC 7660,, Bethesda, MD 20892-7660, US |
| (54) | TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY |
| TUMOR INFILTRATING LYMPHOCYTES FOR USE IN THERAPY |